Clinical Trial

ARISCAT, ASA and LAS VEGAS Risk Scores and the Incidence of Postoperative Pulmonary Complications in Thoracic Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Postoperative pulmonary complications (PPC) are among the main complications after the anesthetic-surgical procedure. It can be said that thoracic surgery results in impaired respiratory function in the postoperatively, due to the decrease in lung volumes and capacities (the vital capacity decreases by approximately 50-60% and functional residual capacity decreases by approximately 30% in the first 24 hours after surgery) diaphragm dysfunction, gas exchange impaired, cough and ineffective mucociliary clearance. Thus, our hypothesis is that the application of preoperative risk scores normally used for non-cardiac and non-thoracic surgeries may be effective on the predictability of the occurrence of CPP in patients undergoing ventilation single-lung. This is a prospective observational study in order to evaluate the performance of the ASA, ARISCAT and LAS VEGAS risk scores for predict the occurrence of postoperative pulmonary complications (PPC) in patients undergoing thoracic surgery with single-lung ventilation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-07.
Status change: Not Yet Recruiting → Recruiting 2025-05-03
Trial Details
NCT Number NCT06404892
Lead Sponsor Hospital Nossa Senhora da Conceicao
Conditions Postoperative Complications
Enrollment 110 participants
Start Date 2024-07-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-06